Concepedia
Statistics
Publications
4
Citations
402
H-Index
Active since
2014
Affiliations
Xcovery (United States)(Current)
The University of Texas MD Anderson Cancer Center
Washington University in St. Louis
Vanderbilt University Medical Center
City of Hope
Kimberly Harrow is an author at Xcovery (United States) specializing in oncology, medicine, and pharmacology.
Publications per year
2014–2019
Ensartinib (X-396) in ALK-Positive Non–Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study
Leora Horn, Jeffrey R. Infante, Karen L. Reckamp et al. · Clinical Cancer Research · 2018 · 190 citations
Medicine, Oncology, Pharmacology +17
Monitoring Therapeutic Response and Resistance: Analysis of Circulating Tumor DNA in Patients With ALK+ Lung Cancer
Leora Horn, Jennifer G. Whisenant, Heather A. Wakelee et al. · Journal of Thoracic Oncology · 2019 · 163 citations · Full text
Medicine, Molecular Genetics, Oncology +17
A phase I trial of X-396, a novel ALK inhibitor, in patients with advanced solid tumors.
Leora Horn, Jeffrey R. Infante, George R. Blumenschein et al. · Journal of Clinical Oncology · 2014 · 39 citations
Medicine, Oncology, Pharmacology +16
MINI01.02: Response and Plasma Genotyping from Phase I/II Trial of Ensartinib (X-396) in Patients (pts) with ALK+ NSCLC
Leora Horn, Heather A. Wakelee, Karen L. Reckamp et al. · Journal of Thoracic Oncology · 2016 · 10 citations · Full text
Medicine, Oncology, Pharmacology +15
1–4 of 4